Abbvie Inc
NYSE:ABBV

Watchlist Manager
Abbvie Inc Logo
Abbvie Inc
NYSE:ABBV
Watchlist
Price: 226.91 USD -0.79% Market Closed
Market Cap: 401B USD

Wall Street
Price Targets

ABBV Price Targets Summary
Abbvie Inc

Wall Street analysts forecast ABBV stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ABBV is 248.59 USD with a low forecast of 189.52 USD and a high forecast of 303.45 USD.

Lowest
Price Target
189.52 USD
16% Downside
Average
Price Target
248.59 USD
10% Upside
Highest
Price Target
303.45 USD
34% Upside
Abbvie Inc Competitors:
Price Targets
MNKD
MannKind Corp
62% Upside
096530
Seegene Inc
67% Upside
VCEL
Vericel Corp
57% Upside
PHIL
Philogen SpA
13% Upside
688382
InventisBio Co Ltd
79% Upside
GYRE
Gyre Therapeutics Inc
130% Upside
600201
Jinyu Bio-Technology Co Ltd
32% Downside

Revenue
Forecast

Revenue Estimate
Abbvie Inc

For the last 13 years the compound annual growth rate for Abbvie Inc's revenue is 9%. The projected CAGR for the next 3 years is 9%.

9%
Past Growth
9%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Abbvie Inc

For the last 13 years the compound annual growth rate for Abbvie Inc's operating income is 11%. The projected CAGR for the next 3 years is 30%.

11%
Past Growth
30%
Estimated Growth
Estimates Accuracy
-18%
Average Miss

Net Income
Forecast

Net Income Estimate
Abbvie Inc

For the last 13 years the compound annual growth rate for Abbvie Inc's net income is 2%. The projected CAGR for the next 3 years is 89%.

2%
Past Growth
89%
Estimated Growth
Estimates Accuracy
-51%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ABBV's stock price target?
Price Target
248.59 USD

According to Wall Street analysts, the average 1-year price target for ABBV is 248.59 USD with a low forecast of 189.52 USD and a high forecast of 303.45 USD.

What is Abbvie Inc's Revenue forecast?
Projected CAGR
9%

For the last 13 years the compound annual growth rate for Abbvie Inc's revenue is 9%. The projected CAGR for the next 3 years is 9%.

What is Abbvie Inc's Operating Income forecast?
Projected CAGR
30%

For the last 13 years the compound annual growth rate for Abbvie Inc's operating income is 11%. The projected CAGR for the next 3 years is 30%.

What is Abbvie Inc's Net Income forecast?
Projected CAGR
89%

For the last 13 years the compound annual growth rate for Abbvie Inc's net income is 2%. The projected CAGR for the next 3 years is 89%.

Back to Top